| MPAKA # | Dzina lazogulitsa | Kufotokozera |
| CPD0004 | Ertugliflozin | Ertugliflozin, yemwe amadziwikanso kuti PF-04971729, ndi choletsa champhamvu komanso chosankha cha sodium-dependent glucose cotransporter 2 komanso wodwala matenda amtundu wa 2 mellitus. |
| Chithunzi cha CPDA0048 | Omarigliptin | Omarigliptin, yemwe amadziwikanso kuti MK-3102, ndiwoletsa komanso wanthawi yayitali wa DPP-4 pochiza matenda amtundu wa 2 kamodzi pa sabata. |
| Mtengo wa CPDA1089 | Retagliptin | Retagliptin, yomwe imadziwikanso kuti SP-2086, ndi DPP-4 inhibitor yomwe ingagwiritsidwe ntchito pochiza matenda amtundu wa 2. |
| Mtengo wa CPDA0088 | Trelagliptin | Trelagliptin, yomwe imadziwikanso kuti SYR-472, ndi inhibitor ya dipeptidyl peptidase-4 (DPP-4) yomwe imapangidwa ndi Takeda pochiza matenda amtundu wa 2 (T2D). |
| CPDA2039 | Linagliptin | Linagliptin, yemwenso amadziwika kuti BI-1356, ndi DPP-4 inhibitor yopangidwa ndi Boehringer Ingelheim pochiza matenda amtundu wachiwiri. |
| Chithunzi cha CPDA0100 | Sitagliptin | Sitagliptin (INN; yomwe idadziwika kale kuti MK-0431 ndipo idagulitsidwa pansi pa dzina lamalonda la Januvia) ndi mankhwala amkamwa a antihyperglycemic (anti-diabetes) a gulu la dipeptidyl peptidase-4 (DPP-4) inhibitor. |
| CPD0854 | LX-4211 | LX-4211 ndi yamphamvu yapawiri SGLT2/1 inhibitor; Antidiabetic wothandizira. |
| Mtengo wa CPDA1553 | LX-2761 | LX2761 ndi SGLT1 inhibitor yomwe imagwira ntchito kwanuko yomwe ili yamphamvu kwambiri mu vitro ndipo imachedwetsa kuyamwa kwa shuga m'matumbo mu vivo kuti glycemic control. |
